1. Amaroq Ltd (£AMRQ) – Charles Walker
🏔️⛏️🌟⚖️💰
Thesis: “AMRQ is a producing gold miner with district-scale potential, critical minerals optionality and unprecedented government backing… Amaroq Minerals is the only company that can actually execute in Greenland. They’ve proven it by building and operating the only modern mine there… They’re exploring for critical minerals at exactly the moment when Western governments are desperate to secure supply chains outside Chinese control. And they’re trading at a substantial discount to fair value based on current assets alone, with none of the strategic upside priced in.”
2. Ashtead Technology (£AT) – Knight Market
⚙️🌊🔩📈
Thesis: “A UK-based subsea services provider that supports offshore energy projects across both oil & gas and renewables… Based on my model, Ashtead’s intrinsic value implies a 18x PE (in line with historical average and peer trading multiples). This points to ~75–80% upside from current levels. In other words, the risk/reward skew is roughly 1:4 in favour of upside...In short: the downside is delay, the upside is compounding — and the market is mispricing both.”
3. Bezant Resources (£BZT) – Charles Walker
⛏️🟠⚡
Thesis: “Bezant holds the Hope and Gorob copper-gold project in Namibia… Bezant is trading like an explorer, but they’re about to become a producer. They’ve got the licenses, the resource, the plant, and they’re in active financing discussions with production targeted to start right as copper supply tightens. The market cap doesn’t reflect any of this yet.”
British Alpha is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
4. Churchill China (£CHH) – Maynard Payton of ShareScope
🍽️🏭📉
Thesis: Churchill China’s shares are trading below book value due to a slump in the hospitality sector, prompting an investigation into whether the crockery manufacturer is a value bargain or a value trap. The analysis finds it is likely not a compelling bargain, citing structural issues like high energy and labour costs, a decline in margin potential, and a reliance on a market recovery.
5. DCC plc (£DCC) – The Modern Investing Newsletter
⚡💶📊
Thesis: “A UK-listed company headquartered in Ireland that operates primarily in the business of energy distribution… A business with a proven track record of growth at an attractive price and a starting dividend yield of 4.3%. With a strong balance sheet, significant free cash flows and a leading market position in European energy distribution, DCC is well positioned to grow profitability at around 10% p.a. for many years... The management team is aligned with shareholders, and a potential sale of the remaining Technology business is a possible catalyst.”
6. EnergyPathways (£EPP) – Charles Walker
🔋🛤️🏛️
Thesis: “EnergyPathways is an integrated energy transition company developing the Marram Energy Storage Hub (MESH), a multi-faceted energy infrastructure project… A company with government-validated nationally significant infrastructure and a clear regulatory pathway forward…. for investors who understand and can tolerate development-stage infrastructure risk, who have appropriate portfolio diversification, and who can commit to long time horizons, EnergyPathways presents a wonderfully asymmetric opportunity.”
Thanks for reading British Alpha! This post is public so feel free to share it.
7. GB Group (£GBG) – Humble Investing
🆔🌍💻💰
Thesis: GB Group (GBG) is a provider of identity, location, and fraud detection software services, aiming to leverage the growth in online transactions with its diversified, high-margin, and largely repeatable revenue streams. Despite a disastrous, highly-priced acquisition of Accuant in 2021 that damaged the share price and loaded debt, the company is now priced for low to no growth, with a repaired balance sheet and new initiatives like ‘GBG Go’ presenting an asymmetrical risk/reward profile.
8. Immupharma (£IMM) – Charles Walker
🧬🩺🔬
Thesis: “The vision ImmuPharma has laid out, of autoimmune disease as a solvable problem rather than a manageable condition, is worth watching closely. Because if they’re right, we might be witnessing the beginning of a fundamental shift in how we think about and treat some of medicine’s most intractable diseases. This could be worth hundreds of millions.”
9. Keller Group (£KLR) – D Invests
🏗️🛠️⛏️
Thesis: “Keller is a global leader in geotechnical solutions… It looks like an excellent business with huge competitive advantages over peers which should bode well for future contract wins and growth. I know many investors will dismiss the company due to its low margin business model and the cyclicality inherent in its end markets but this is where I see opportunity and why I’m considering adding to the portfolio “No position yet”, with an enterprise value of £1.23bn and LTM EBITDA of £265 million resulting in EV/EBITDA of 4.1x looks like excellent value.”
10. Kitwave Group (£KITW) – Humble Investing
📦🍽️📈
Thesis: Kitwave is a wholesale distributor of chilled and ambient foods to the independent retail sector and Foodservice division, making money by using its scale to buy products cheaply and distributing them for a profit margin. The investment thesis suggests the company is currently priced for no growth at very low valuations, offering limited downside while presenting significant upside potential from its proven management team continuing to execute accretive acquisitions in the highly fragmented UK market.
11. McBride PLC (£MCB) – 10Bagger
🧴🏠📉
Thesis: “Europe’s leading private label manufacturer for household and professional cleaning products… McBride is trading at very attractive multiples for what should be considered a stable, low-growth, business. Once the company consistently demonstrates its ability to defend and maintain the current higher operating margins through successive earnings reports, I believe the market will re-rate the stock. The only potential short-term catalyst is a M&A announcement, which is likely to occur eventually but is unpredictable. Until then, patience is required.”
12. MS International plc (£MSI) – Silba
🏢🕰️🛡️
Thesis: “A British family firm’s accidental transformation into a defence contractor worth watching… At its core, MS International is a bet on institutional inertia versus generational change. The bull case requires believing that switching costs in defence systems and decades-old customer relationships matter more than working capital management or modern governance. The bear case says family control, aging leadership, and customer concentration are ticking time bombs that financial engineering can’t defuse.”
13. MS International plc (£MSI) – Maynard Payton of ShareScope
📈⚔️👥
Thesis: MSI has shifted from modest past performance to rapid growth driven by large defence contracts, especially with the US Navy, boosting profits and share price. Its solid balance sheet, high margins, and dividend increases support its status as a quality stock, though earnings may fluctuate due to contract timing and working capital needs. Despite governance concerns, MSI’s positioning in a growing defence market suggests it could be a significant long-term winner, potentially a multi-bagger if growth continues.
14. Rolls-Royce Holdings PLC (£RR) – European Hidden Gem Stocks
✈️⚙️💪
Thesis: “A leading defence contractor and aerospace manufacturer with a wide range of products… Overall I am very confident that Rolls Royce will continue to deliver. What I really like about this company it is has several pathways for growth and all of these are aligned with mega trends that are going to play out over the next decade.”
15. Shell plc (£SHEL) – Adaptive Asset Analytics
🛢️📉💵
Thesis: “Shell has credible cash returns, portfolio simplification, and a scaled LNG moat—with real but manageable cycle risk. If you want integrated energy beta with disciplined buybacks and an improving per-share math, SHEL fits. The stock isn’t “cheap at any price,” but on mid-cycle assumptions the risk-reward skews moderately positive to ~$83 over 12 months, with dividends and buybacks paying you to wait.”
16. Wise plc (£WISE) – The Quality Investor
💸🌐🚀
Thesis: A digital-first platform enabling cheap, fast, and transparent international money transfers, Wise combines strong financials, founder-led leadership, and a large market opportunity with a shared economies scale model that reinforces customer loyalty, and a durable moat built on network effects, regulation, and trust.
17. Wise plc (£WISE) – ThinkAnew of Value Investors Club
🌏🔄💰
Thesis: “Wise is a cross-border payment and technology company that helps its customers, both individuals and businesses (mostly SMBs), move money across borders at a lower cost than most of its competitors… If you believe in the infrastructure Wise has built over the last 14 years, and that it’ll get a bit better/stronger over the next 5 years, things should not go to hell over the next 3-4 years and it could be a decent 15-20% IRR during the timeframe.”

Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.